Report overview
The global Point of Care Molecular Diagnostics Technology market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
We have surveyed the Point of Care Molecular Diagnostics Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Point of Care Molecular Diagnostics Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care Molecular Diagnostics Technology. This report contains market size and forecasts of Point of Care Molecular Diagnostics Technology in global, including the following market information:
Global Point of Care Molecular Diagnostics Technology market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Point of Care Molecular Diagnostics Technology companies in 2024 (%)
Total Market by Segment:
Global Point of Care Molecular Diagnostics Technology market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Point of Care Molecular Diagnostics Technology market segment percentages, by Type, 2024 (%)
Polymerase Chain Reaction
In Situ Hybridization
Gene Chips
Next Generation Sequencing
Global Point of Care Molecular Diagnostics Technology market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Point of Care Molecular Diagnostics Technology market segment percentages, by Application, 2024 (%)
Hospitals and Clinics
Independent Clinical Laboratories
Global Point of Care Molecular Diagnostics Technology market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Point of Care Molecular Diagnostics Technology market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Point of Care Molecular Diagnostics Technology revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Point of Care Molecular Diagnostics Technology revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Accelerate Diagnostics
Ador Diagnostics
Beckman Coulter
Becton, Dickinson and Company
Binx Health
Biocartis
bioM�rieux
Bio-Rad Laboratories
Bosch Healthcare Solutions
Curetis
Eurofins Scientific
Genetic Signatures
Grifols
Hibergene Diagnostics
Lumos Diagnostics
Roche
Siemens
Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Point of Care Molecular Diagnostics Technology, market overview.
Chapter 2: Global Point of Care Molecular Diagnostics Technology market size in revenue.
Chapter 3: Detailed analysis of Point of Care Molecular Diagnostics Technology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Point of Care Molecular Diagnostics Technology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
